The 22nd meeting of the Biopharmaceutical Applied Statistics Symposium (BASS XXII) will be held November 2–6 at the Crowne Plaza Washington DC-Rockville.

At least 16 one-hour tutorials on diverse topics pertinent to the research, clinical development, and regulation of pharmaceuticals will be presented November 2–4 by speakers from academia, the pharmaceutical industry, and the U.S. Food and Drug Administration (FDA). Two parallel two-day short courses will be presented November 6–7.

Highlights of BASS XXII will be the keynote address November 3, with a reception dinner following, and the FDA/industry/academia session November 4.

BASS is a nonprofit entity established to raise funds to support graduate studies in biostatistics. To date, BASS has provided support to more than 50 master’s or doctoral biostatistics students.

For further information, contact the BASS registrar at  Rewhitworth@gmail.com, Andreas Sashegyi at (317) 532-7414 or aisasheg@lilly.com, or Karl Peace at (912) 225-3713 or peacekarl@frontier.com.